Author

R. W. Hendriks

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:GWAS / association mapping· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Stikker· 1 shared C. J. Binder· 1 shared C. Pottgens· 1 shared G. Kraal· 1 shared G. Stik· 1 shared H. L. Matlung· 1 shared H. Olsman· 1 shared J. Geissler· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. Stikker

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Severe COVID-19 associated variants linked to chemokine receptor gene control in monocytes and macrophages

B. Stikker, G. Stik, R. W. Hendriks, R. Stadhouders

The paper identifies 3p21.31 as a risk locus for severe COVID-19 by linking risk SNPs to increased expression of chemokine receptors in monocytes and macrophages through CTCF-dependent regulatory elements.

bioRxiv · Jan 22, 2021Immunology

SIRPalpha on mouse B1 cells restricts lymphoid tissue migration and natural antibody production

T. van den Berg, K. Franke, S. Y. Pillai, M. Hoogenboezem, M. J. J. Gijbels, H. L. Matlung, J. Geissler, H. Olsman, C. Pottgens, P. J. van Gorp, M. Ozsvar-Kozma, Y. Saito, T. Matozaki, T. W. Kuijpers, R. W. Hendriks, , M. P. J. de Winther

This study shows SIRPalpha on mouse B1 cells limits migration and natural antibody production, suggesting it as a therapeutic target for atherosclerosis.

bioRxiv · May 13, 2020Immunology